This website collects cookies to deliver better user experience. Cookie Policy
Accept
Sign In
The Wall Street Publication
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Reading: Mainz Biomed Reports Breakthroughs in Non-Invasive Cancer Testing
Share
The Wall Street PublicationThe Wall Street Publication
Font ResizerAa
Search
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© 2024 The Wall Street Publication. All Rights Reserved.
The Wall Street Publication > Blog > Health > Mainz Biomed Reports Breakthroughs in Non-Invasive Cancer Testing
HealthTrending

Mainz Biomed Reports Breakthroughs in Non-Invasive Cancer Testing

Editorial Board Published April 23, 2025
Share
Mainz Biomed Reports Breakthroughs in Non-Invasive Cancer Testing
SHARE

April 24th, 2025 – Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company, is emerging as a formidable force in the evolving landscape of early cancer detection. With significant progress across clinical research, strategic partnerships, and financial performance, the Germany-based firm is laying the groundwork for a new era in non-invasive cancer screening.

 In 2024, Mainz Biomed reached several pivotal milestones that underscore its growing influence in the diagnostics industry. Among the most significant achievements, the company confirmed full compliance with all Nasdaq listing requirements — a foundational step that solidifies investor confidence as it scales operations globally. The momentum has been driven largely by Mainz’s flagship program, the eAArly DETECT 2 study, which builds upon its earlier clinical success. Designed to enhance screening accuracy for colorectal cancer, the trial has already delivered promising results.

 In preliminary data from the company’s earlier study, Mainz reported 97% sensitivity for colorectal cancer, 82% for advanced precancerous lesions, and a 100% detection rate for high-grade dysplasia—metrics that may redefine industry standards if confirmed in the current phase. The company’s commercially available ColoAlert® test—an at-home, non-invasive screening kit for colorectal cancer—is also gaining traction, particularly in the European market. Revenue from its lab partner network rose 33% year-over-year, a signal of accelerating demand and growing physician adoption. Beyond colorectal cancer, Mainz is expanding its clinical ambitions.

 The firm is collaborating with Liquid Biosciences on what could become a groundbreaking blood-based test for pancreatic cancer—one of the deadliest malignancies due to typically late-stage diagnosis. Preliminary studies suggest 95% sensitivity and 98% specificity, figures that, if validated, could mark a paradigm shift in early pancreatic cancer detection.

Strategic alliances have further strengthened Mainz’s outlook. A high-profile partnership with Thermo Fisher Scientific aims to develop next-generation colorectal cancer diagnostics. Meanwhile, a collaboration with Quest Diagnostics is facilitating a major U.S.-based clinical trial designed to support FDA regulatory submission, setting the stage for potential American market entry.

“We are at an inflection point,” said Mainz Biomed CEO Guido Baechler in a recent statement. “Our mission is to transform early cancer detection from a possibility into a global reality.”

While the oncology diagnostics space remains crowded, Mainz’s integrated approach—combining cutting-edge RNA and DNA-based biomarkers with robust distribution channels—positions it to compete aggressively in both European and U.S. markets. Mainz Biomed could be on the cusp of redefining how—and when—we detect some of the world’s most lethal cancers.

https://mainzbiomed.com/

Share This Article
Twitter Email Copy Link Print
Previous Article Sophie Nyweide Explanation for Dying: Former Little one Star Was Pregnant at Time of Passing, Dying Certificates Confirms Sophie Nyweide Explanation for Dying: Former Little one Star Was Pregnant at Time of Passing, Dying Certificates Confirms
Next Article Securing the Web of Issues: Methods to Shield Related Gadgets Securing the Web of Issues: Methods to Shield Related Gadgets

Editor's Pick

Nicki Minaj Calls Cardi B’s Daughter ‘Ugly’; Cardi Shoots Again That Nicki’s Son Is Nonverbal Because of Drug Use Throughout Being pregnant

Nicki Minaj Calls Cardi B’s Daughter ‘Ugly’; Cardi Shoots Again That Nicki’s Son Is Nonverbal Because of Drug Use Throughout Being pregnant

Studying Time: 3 minutes The Nicki Minaj vs. Cardi B beef has been occurring for years. Like, mainly for so…

By Editorial Board 4 Min Read
The Seasonal Reset: 38 Simple Fall Updates for Max Coziness
The Seasonal Reset: 38 Simple Fall Updates for Max Coziness

The primary crisp morning of fall at all times seems like a…

8 Min Read
BMW recollects almost 200K autos as a consequence of fireplace danger, says house owners ought to park exterior
BMW recollects almost 200K autos as a consequence of fireplace danger, says house owners ought to park exterior

Try what's clicking on FoxBusiness.com. Practically 200,000 BMW house owners are being…

3 Min Read

Oponion

Bridgeport’s Hansberry, McCarthy Win No. 2 Doubles Title at Huge 10 Tennis Championships

Bridgeport’s Hansberry, McCarthy Win No. 2 Doubles Title at Huge 10 Tennis Championships

Bridgeport Excessive College’s duo of Madison Hansberry and Addi McCarthy…

May 4, 2025

Prediction: 2025 is the yr quantum computing advances from bodily qubits to logical qubits

Quantum computing has lengthy been a…

November 19, 2024

Rick Derringer dies at 77; musician who had successful with ‘Hang On Sloopy’ additionally produced songs for ‘Weird Al’ Yankovic

Related Press Guitarist and singer Rick…

May 27, 2025

Prince William Reveals Royals’ Christmas Plans: We Invited 45 Individuals (However Not Harry & Meghan)!

Prince William has opened up about…

December 16, 2024

All of the worst individuals are getting in on the deportation motion

These employees normally had J-1 visas,…

August 13, 2025

You Might Also Like

“Journey Within” Masterclass with Gurudev Sri Sri Ravi Shankar
LifestyleTrending

“Journey Within” Masterclass with Gurudev Sri Sri Ravi Shankar

World-Renowned Meditation Leader Returns to North Texas Dallas, TX — This fall, the Art of Living Foundation in Dallas will…

5 Min Read
Interview with Canadian Futures Trader: Inside the Journey of a Modern Futures Trader
LifestyleTrending

Interview with Canadian Futures Trader: Inside the Journey of a Modern Futures Trader

Paul, Futures Times: Thanks for joining us today, Chris. To start off, can you tell us about your background and…

7 Min Read
Violet Brandani: Redefining Digital Streaming With Charm and Creativity
EntertainmentTrending

Violet Brandani: Redefining Digital Streaming With Charm and Creativity

In today’s fast-paced digital era, countless creators appear on our screens, but only a few manage to truly capture our…

3 Min Read
Genesis Quantum Mining AI: The Rise of a Global Powerhouse
TechTrending

Genesis Quantum Mining AI: The Rise of a Global Powerhouse

London, UK — The world may be witnessing the birth of the next unicorn. Genesis Quantum Mining AI, a London-registered…

4 Min Read
The Wall Street Publication

About Us

The Wall Street Publication, a distinguished part of the Enspirers News Group, stands as a beacon of excellence in journalism. Committed to delivering unfiltered global news, we pride ourselves on our trusted coverage of Politics, Business, Technology, and more.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 The Wall Street Publication. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?